Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. (MIRM) Stock Overview

Explore Mirum Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MIRM●NASDAQ
HealthcareBiotechnology
$96.31
$0.76(0.78%)
U.S. Market opens in 61h 13m

Mirum Pharmaceuticals, Inc. (MIRM)

Meyka AI Score

Z

Key Financials

Market Cap5.9B
P/E Ratio-6.63
EPS (TTM)$-14.55
ROE-4.10%
Fundamental Analysis

AI Price Forecasts

1 Month$118.12
3 Months$136.01
1 Year Target$130.18

MIRM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Mirum Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MIRM on the NASDAQ shows an RSI of 37.33, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $130.18 for the NASDAQ listing.

Key metrics behind Mirum Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -6.63 and a market capitalization of 5.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MIRM on the NASDAQ.

Price Performance (NASDAQ: MIRM)

1-Day Change
-0.78%
5-Day Change
-1.75%
1-Month Change
-17.72%
3-Month Change
-4.33%
6-Month Change
-8.42%
Year-to-Date (YTD) Change
21.93%
1-Year Change
39.46%
3-Year Change
268.30%
5-Year Change
555.17%
All-Time (Max) Change
629.07%

Contact Information

https://www.mirumpharma.com
650 667 4085
989 East Hillsdale Boulevard, Foster City, CA, 94404

Company Facts

4,180 Employees
IPO DateJul 18, 2019
CountryUS
Actively Trading

Frequently Asked Questions